Li Su
Impact in
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
-
- Cancer-related molecular mechanisms research
Papers in
-
- Retinal Diseases and Treatments 7
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Xun Xu (8 shared papers)Srinivas Reddy Sadda (8 shared papers)Hui‐Fen Huang (2 shared papers)Yang Li (1 shared paper)Ting Liu (1 shared paper)Xinfeng Zhang (1 shared paper)Yong‐Sok Ji (3 shared papers)Chun Wang (3 shared papers)
- Journals
- Translational Vision Science & Technology (3 papers)Annals of Hematology (3 papers)Drug Design Development and Therapy (2 papers)Frontiers in Pharmacology (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Li Su
68 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 129
- Ophthalmology 182
- Cancer Research 156
- Instrumentation 35
- Animal Science and Zoology 87
- Radiology, Nuclear Medicine and Imaging 181
Countries citing papers authored by Li Su
This map shows the geographic impact of Li Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Su more than expected).
Fields of papers citing papers by Li Su
This network shows the impact of papers produced by Li Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Su. The network helps show where Li Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 136 | |
| 2 | 2020 | 102 | |
| 3 | 2020 | 93 | |
| 4 | Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer. | 2015 | 83 |
| 5 | 2016 | 61 | |
| 6 | 2014 | 56 | |
| 7 | 2017 | 56 | |
| 8 | 2017 | 55 | |
| 9 | 2017 | 54 | |
| 10 | 2005 | 50 | |
| 11 | 2010 | 43 | |
| 12 | 2014 | 35 | |
| 13 | 2020 | 33 | |
| 14 | 1973 | 32 | |
| 15 | 2006 | 31 | |
| 16 | 2020 | 29 | |
| 17 | 1971 | 29 | |
| 18 | 2016 | 28 | |
| 19 | 2016 | 26 | |
| 20 | 2012 | 21 |
About Li Su
Li Su is a scholar working on Ophthalmology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Hematology and Electrical and Electronic Engineering, having authored 72 papers that have together received 1.4k indexed citations. Recurring topics across this work include Photonic and Optical Devices (9 papers), Retinal Diseases and Treatments (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Microwave Engineering and Waveguides (4 papers), Retinal Imaging and Analysis (3 papers), Advanced Antenna and Metasurface Technologies (3 papers), Antenna Design and Analysis (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Ophthalmology (182 citations), Cancer Research (156 citations), Instrumentation (35 citations), Animal Science and Zoology (87 citations) and Radiology, Nuclear Medicine and Imaging (181 citations). Li Su has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Xun Xu, Srinivas Reddy Sadda, Hui‐Fen Huang, Yang Li, Ting Liu, Xinfeng Zhang, Yong‐Sok Ji, Chun Wang, Haitao Bai and Youwen Qin. Their work appears in journals such as Translational Vision Science & Technology, Annals of Hematology, Drug Design Development and Therapy, Frontiers in Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.